Kolade Adegoke

5PUBLICATIONS
14CO-AUTHORS
Medical infection agents (incl. prions)Medical molecular engineering of nucleic acids and proteinsPoverty, inclusivity and wellbeingGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 24, 2025
Retraction Note: Comparing Moderna's mRNA-1083 and Pfizer's dual-target mRNA vaccines for influenza and COVID-19.

Adewunmi Akingbola, Abiodun Adegbesan, Kolade Adegoke

|Aug 22, 2025
Antimicrobial resistance to colistin in neonates: epidemiological insights and public health implications in Nigeria - a mini review.

Adewunmi Akingbola, Abiodun Christopher Adegbesan, Olaoluwa Olorunfemi

|May 24, 2025
Comparing Moderna's mRNA-1083 and Pfizer's dual-target mRNA vaccines for influenza and COVID-19.

Adewunmi Akingbola, Abiodun Adegbesan, Kolade Adegoke

|Apr 29, 2025
Chandipura Virus Resurgence in India: Insights Into Diagnostic Tools, Antiviral Development, and Public Health Implications.

Adewunmi Akingbola, Abiodun Adegbesan, Kolade Adegoke

|Jan 18, 2025
The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV).

Adewunmi Akingbola, Abiodun Adegbesan, Olajumoke Adewole

Pageof 1